CMS vs SGMO · P/E 20, $22.42B cap vs rev $57.8M
CMS Energy Corporation (CMS) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
CMS does not have a complete income-statement cache yet.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
CMS currently screens at market cap $22.42B and trailing P/E 20.1. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the CMS and SGMO stock pages for the full models.
Not investment advice.